private financing
Adaptin Bio Goes Public Through Reverse Merger, Completes $7.7M Private Placement
The firm will use the proceeds to advance its bispecific T-cell engager candidate APTN-101 in glioblastoma.
Proscia Nabs $50M in Funding to Support Commercialization of Digital Pathology Software
The firm said that the money will support work with OEM partners and the expanded development and integration of artificial intelligence-based tools.
MSInsight Nabs €1.6M in Seed Funding to Develop Microsatellite Instability Cancer Dx Software
The French cancer diagnostics startup plans to obtain regulatory approval for its MSIcare software as an in vitro diagnostic medical device for MSI cancers.
Aptose Biosciences Enters $25M Common Shares Purchase Agreement
The firm will offer up to 12,030,218 common shares for Keystone Capital Partners to sell and is expecting to net around $2.1 million in gross proceeds.
A2 Biotherapeutics Raises $80M in Series C Funding
The firm will use the funding to advance ongoing clinical trials of its autologous cell therapies for solid tumors.
Dec 16, 2024
Promise Bio Closes $8.3M Seed Round
Oct 25, 2024
Alpha-9 Oncology Raises $175M in Series C Financing
Oct 16, 2024
Sunbird Bio Nabs $14M in Financing
Aug 21, 2024
PreciseDx Raises $20.7M in Series B Round
Aug 8, 2024
IDRx Raises $120M in Series B Financing
Aug 2, 2024
Outpace Bio Raises $144M in Series B Financing
Jul 16, 2024